RSAD1

Across TCGA pan-cancer cohorts, RSAD1 mass-spec protein is linked to patient survival in 4 of 34 cancer types, making it a survival-associated RSAD1 data layer compared with 26 for mass-spec protein and 2 for mutation status.

The strongest signal is observed in lung squamous cell carcinoma (LSCC), where higher RSAD1 mass-spec protein is associated with better overall survival. In most high-consensus cancer types, elevated RSAD1 expression acts as an unfavorable survival marker, although some lineages such as LSCC show a favorable association.

LSCC, LUAD, and HNSC are the cancer types where RSAD1 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LSCC	OS	Quartile	All	1.000	0.863	.021	11	view →
LUAD	DFS	Median	All	0.640	0.853	.028	4	view →
HNSC	DFS	Quartile	All	0.415	0.834	.015	4	view →
CCRCC	OS	Tertile	All	0.724	1.000	.026	1	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

RSAD1–LSCC (OS)

Open the LSCC breakdown →